API Products in R&D THERAPEUTIC CATEGORY STATUS
Darolutamide Oncology Developed
Everolimus Oncology Developed
Elacestrant Oncology Under developed
Exemestane Oncology Under developed
Osimertinib Oncology Under developed
Resmetirom NASH Under developed
Umeclidinium Bromide COPD Under developed
Vilanterol COPD Under developed
Rimegepant Migraine Headache Pilot
Vibegron Overactive Bladder (OAB) Pilot
Tirzepatide Type ll diabetic Under development
Vosortide Achondroplasia Under developed
Inclisiran Hyperlipidemia(siRNA) Under development
Risdiplam SMA Under development
Vutrisiran ATTR(siRNA) Under development
Filgotinib Rheumatoid arthritis(JAK1) Developed
Upadacitinib Rheumatoid arthritis(JAK1) Under development
Estetrol Estrogen Under development
Progesterone Progestogen Pilot
Methylprednisolone Anti-inflammatory Under development
Zuranolone
MDD&PPD
Under development

※ Disclaimer:

Products protected by valid patents in this list are for laboratory analytical/research purposes only and are not offered for sale in countries or area wherethe sale of such products constitutes a patent infringement.Any liability is at buyer's risk.